GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vycor Medical Inc (OTCPK:VYCO) » Definitions » Shiller PE Ratio

Vycor Medical (Vycor Medical) Shiller PE Ratio : (As of May. 17, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Vycor Medical Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Vycor Medical Shiller PE Ratio Historical Data

The historical data trend for Vycor Medical's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vycor Medical Shiller PE Ratio Chart

Vycor Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vycor Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vycor Medical's Shiller PE Ratio

For the Medical Devices subindustry, Vycor Medical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vycor Medical's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vycor Medical's Shiller PE Ratio falls into.



Vycor Medical Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Vycor Medical's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Vycor Medical's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/129.4194*129.4194
=0.000

Current CPI (Dec. 2023) = 129.4194.

Vycor Medical Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.090 99.695 -0.117
201406 -0.120 100.560 -0.154
201409 -0.120 100.428 -0.155
201412 -0.060 99.070 -0.078
201503 -0.070 99.621 -0.091
201506 -0.040 100.684 -0.051
201509 -0.050 100.392 -0.064
201512 -0.030 99.792 -0.039
201603 -0.060 100.470 -0.077
201606 -0.030 101.688 -0.038
201609 -0.040 101.861 -0.051
201612 -0.050 101.863 -0.064
201703 -0.030 102.862 -0.038
201706 -0.020 103.349 -0.025
201709 -0.030 104.136 -0.037
201712 -0.020 104.011 -0.025
201803 -0.020 105.290 -0.025
201806 -0.020 106.317 -0.024
201809 -0.010 106.507 -0.012
201812 -0.020 105.998 -0.024
201903 -0.010 107.251 -0.012
201906 -0.010 108.070 -0.012
201909 -0.020 108.329 -0.024
201912 -0.010 108.420 -0.012
202003 -0.010 108.902 -0.012
202006 -0.010 108.767 -0.012
202009 -0.010 109.815 -0.012
202012 0.000 109.897 0.000
202103 -0.010 111.754 -0.012
202106 0.000 114.631 0.000
202109 -0.010 115.734 -0.011
202112 -0.010 117.630 -0.011
202203 -0.010 121.301 -0.011
202206 -0.003 125.017 -0.003
202209 -0.010 125.227 -0.010
202212 0.000 125.222 0.000
202303 -0.005 127.348 -0.005
202306 0.002 128.729 0.002
202309 -0.010 129.860 -0.010
202312 0.000 129.419 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vycor Medical  (OTCPK:VYCO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Vycor Medical Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Vycor Medical's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vycor Medical (Vycor Medical) Business Description

Traded in Other Exchanges
N/A
Address
951 Broken Sound Boulevard, Suite 320, Boca Raton, FL, USA, 33487
Vycor Medical Inc is engaged in designing, developing and marketing medical devices for use in neurosurgery in the United States. It has developed ViewSite Brain Access System, which helps to reduce brain tissue trauma that arises from excessive pressure at the edges of the blade. It also provides non-invasive rehabilitation therapies for patients having disorders resulting from neurological brain damage caused by a stroke. The company operates through two segments: Vycor Medical, which focuses on devices for neurosurgery; and NovaVision, which focuses on neurostimulation therapies and diagnostic devices for the treatment and screening of visual field loss. The majority of the revenue comes from the Vycor Medical segment in the United States.
Executives
David Cantor director, officer: President 1 PORTMAN HOUSE HUE STREET, ST HELIER, JERSEY CHANNEL ISLANDS X0 00000
Adrian Liddell director, officer: Chairman ROSEMOUNT, LYNCOMBE VALE ROAD, BATH HI BA2 4LP
Peter C Zachariou director, 10 percent owner, officer: Chief Executive Officer C/O QUE MANAGEMENT INC, 180 VENICK 13RH FL, NEW YORK NY 10014
Lowell Rush director C/O DIRECT INSITE CORP., 500 EAST BROWARD BOULEVARD, SUITE 1550, FORT LAUDERDALE FL 33394
Oscar Bronsther director 4 AUTUMNWOOD COURT, THE WOODLANDS TX 77380
Steven Girgenti director C/O HEALTHWORLD CORP, 100 AVENUE OF THE AMERICAS, NEW YORK NY 10013
Fountainhead Capital Management Ltd 10 percent owner PORTMAN HOUSE HUE STREET, ST HELIER, JERSEY CHANNEL ISLANDS X0 JE45RP

Vycor Medical (Vycor Medical) Headlines